Status:
COMPLETED
Inspiratory Flow Parameters and Handling of Easyhaler and Turbuhaler Inhalers
Lead Sponsor:
Orion Corporation, Orion Pharma
Conditions:
Asthma
Pulmonary Disease, Chronic Obstructive
Eligibility:
All Genders
6+ years
Phase:
NA
Brief Summary
The aim of the study is to measure the inspiratory flow that the different patient groups (asthmatic children, adults and elderly, as well as chronic obstructive pulmonary disease (COPD) patients) gen...
Eligibility Criteria
Inclusion
- Written informed consent obtained.
- Documented diagnosis of asthma and/or COPD (a range of different severities for both diseases).
- Age: 6 years or above.
Exclusion
- Any severe chronic respiratory disease other than asthma or COPD.
- Acute respiratory infection.
- Concurrent participation in a clinical drug study.
- Inability to perform repeatable spirometric measurements.
- Any medical condition that in the opinion of the investigator would endanger the subject if he/she participates in the study (such as contraindications to spirometry).
Key Trial Info
Start Date :
September 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2010
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT00984906
Start Date
September 1 2009
End Date
March 1 2010
Last Update
June 8 2010
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Jorvi hospital
Helsinki, Finland
2
Skin and Allergy hospital
Helsinki, Finland
3
Northern General Hospital
Sheffield, United Kingdom
4
Sheffield Children's Hospital
Sheffield, United Kingdom